This conclusion was molecularly confirmed by recent observations that cisplatin resistance is correlated with reduced expression of LRRC8A in human cancer cells (Planells-Cases et al., 2015; Sørensen et al., 2016a, b; Thorsteinsdottir et al., 2016). Here, LRRC8A is linked to cancer.